Knockdown of UCA1 by suppressing PKM2 through inactivation of the mTOR pathway could inhibit the glycolysis of NSCLC cells. UCA1 silencing could reduce the glucose consumption and lactate production. This evidence concerns the gene MTOR and non-small cell lung carcinoma.